Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Non-Current Assets (2011 - 2026)

Palatin Technologies' (PTN) quarterly Non-Current Assets came in at $440089.0 in Q1 2026, down 11.13% on a YoY basis from $495216.0 in Q1 2025, and down 4.38% quarter-over-quarter from $460249.0 in Q4 2025.

Analysis

Palatin Technologies (PTN) Non-Current Assets (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Non-Current Assets for 15 consecutive years, with $440089.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 11.13% year-over-year to $440089.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 48.72% YoY), and the FY2025 full-year result was $347526.0, down 64.27% from the prior year.
  • Non-Current Assets slipped to $440089.0 in Q1 2026 per PTN's latest filing, from $460249.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.6 million in Q2 2023 and bottomed at $244882.0 in Q3 2025.
  • Historically, Non-Current Assets has averaged $1.0 million across 5 years, with a median of $1.1 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Non-Current Assets gained 9.71% in 2023, then slumped 69.49% in 2025.
  • Over 5 years, Non-Current Assets stood at $1.4 million in 2022, then slipped by 8.13% to $1.3 million in 2023, then sank by 51.1% to $640301.0 in 2024, then declined by 28.12% to $460249.0 in 2025, then dropped by 4.38% to $440089.0 in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $440089.0, $460249.0, and $244882.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 564.41 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 440,089.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 440,089.00
Dec 31, 2025 460,249.00
Sep 30, 2025 244,882.00
Jun 30, 2025 347,526.00
Mar 31, 2025 495,216.00
Dec 31, 2024 640,301.00
Sep 30, 2024 802,610.00
Jun 30, 2024 972,598.00
Mar 31, 2024 1.14 Mn
Dec 31, 2023 1.31 Mn
Sep 30, 2023 1.44 Mn
Jun 30, 2023 1.62 Mn
Mar 31, 2023 1.37 Mn
Dec 31, 2022 1.43 Mn
Sep 30, 2022 1.46 Mn
Jun 30, 2022 1.47 Mn
Mar 31, 2022 1.57 Mn
Dec 31, 2021 1.63 Mn
Sep 30, 2021 1.34 Mn
Jun 30, 2021 1.39 Mn